<VariationArchive RecordType="classified" VariationID="1710492" VariationName="NM_000512.5(GALNS):c.374del (p.Pro125fs)" VariationType="Deletion" Accession="VCV001710492" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-22" DateCreated="2022-10-22" MostRecentSubmission="2022-10-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1708903" VariationID="1710492">
      <GeneList>
        <Gene Symbol="GALNS" FullName="galactosamine (N-acetyl)-6-sulfatase" GeneID="2588" HGNC_ID="HGNC:4122" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88813734" stop="88856947" display_start="88813734" display_stop="88856947" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88880141" stop="88923373" display_start="88880141" display_stop="88923373" Strand="-" />
          </Location>
          <OMIM>612222</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000512.5(GALNS):c.374del (p.Pro125fs)</Name>
      <CanonicalSPDI>NC_000016.10:88841039:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88841040" stop="88841040" display_start="88841040" display_stop="88841040" variantLength="1" positionVCF="88841039" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88907448" stop="88907448" display_start="88907448" display_stop="88907448" variantLength="1" positionVCF="88907447" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>p. Pro125Argf sTer4</Name>
      </OtherNameList>
      <ProteinChange>P125fs</ProteinChange>
      <ProteinChange>P131fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.88841041del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.88841041del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.88907449del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.88907449del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008667.1" sequenceAccession="NG_008667" sequenceVersion="1" change="g.20927del">
            <Expression>NG_008667.1:g.20927del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000512.5" sequenceAccession="NM_000512" sequenceVersion="5" change="c.374del" MANESelect="true">
            <Expression>NM_000512.5:c.374del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000503.1" sequenceAccession="NP_000503" sequenceVersion="1" change="p.Pro125fs">
            <Expression>NP_000503.1:p.Pro125fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001323543.2" sequenceAccession="NM_001323543" sequenceVersion="2" change="c.-182del">
            <Expression>NM_001323543.2:c.-182del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001323544.2" sequenceAccession="NM_001323544" sequenceVersion="2" change="c.392del">
            <Expression>NM_001323544.2:c.392del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001310473.1" sequenceAccession="NP_001310473" sequenceVersion="1" change="p.Pro131fs">
            <Expression>NP_001310473.1:p.Pro131fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <FunctionalConsequence Value="Unknown function" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000512.5(GALNS):c.374del (p.Pro125fs) AND Mucopolysaccharidosis, MPS-IV-A" Accession="RCV002291514" Version="1">
        <ClassifiedConditionList TraitSetID="175">
          <ClassifiedCondition DB="MedGen" ID="C0086651">Mucopolysaccharidosis, MPS-IV-A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-10-22" MostRecentSubmission="2022-10-22">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="175" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3036" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MPS 4A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio A disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactosamine-6-sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type IV A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio syndrome A, mild</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-IV-A</ElementValue>
                <XRef ID="Morquio+syndrome+A/4876" DB="Genetic Alliance" />
                <XRef ID="7259005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS IVA</ElementValue>
                <XRef Type="MIM" ID="253000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio syndrome A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis Type IVA</ElementValue>
                <XRef ID="NBK148668" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS4A</ElementValue>
                <XRef Type="MIM" ID="253000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3785" />
                <XRef ID="3785" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of mucopolysaccharidosis IVA (MPS IVA) is a continuum that ranges from a severe and rapidly progressive early-onset form to a slowly progressive later-onset form. Children with MPS IVA typically have no distinctive clinical findings at birth. The severe form is usually apparent between ages one and three years, often first manifesting as kyphoscoliosis, genu valgum (knock-knee), and pectus carinatum; the slowly progressive form may not become evident until late childhood or adolescence, often first manifesting as hip problems (pain, stiffness, and Legg Perthes disease). Progressive bone and joint involvement leads to short stature, and eventually to disabling pain and arthritis. Involvement of other organ systems can lead to significant morbidity, including respiratory compromise, obstructive sleep apnea, valvular heart disease, hearing impairment, visual impairment from corneal clouding, dental abnormalities, and hepatomegaly. Compression of the spinal cord is a common complication that results in neurologic impairment. Children with MPS IVA have normal intellectual abilities at the outset of the disease.</Attribute>
                <XRef ID="NBK148668" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23844448</ID>
                <ID Source="BookShelf">NBK148668</ID>
              </Citation>
              <XRef ID="309297" DB="Orphanet" />
              <XRef ID="582" DB="Orphanet" />
              <XRef ID="C0086651" DB="MedGen" />
              <XRef ID="MONDO:0009659" DB="MONDO" />
              <XRef Type="MIM" ID="253000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5049609" SubmissionDate="2022-10-13" DateLastUpdated="2022-10-22" DateCreated="2022-10-22">
        <ClinVarSubmissionID localKey="SUB12140418" submittedAssembly="GRCh38" title="SUB12140418" />
        <ClinVarAccession Accession="SCV002583289" DateUpdated="2022-10-22" DateCreated="2022-10-22" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A homozygous single base pair deletion in exon 4 of the GALNS gene (chr16:g. 88841040 del; Depth: 121x) that results in a frameshift and premature truncation of the protein 4 amino acids downstream to codon 125 (p.Pro125ArgfsTer4; ENST00000268695.10) was detected (Table). This variant has not been reported in the 1000 genomes and gnomAD databases and has a minor allele frequency of 0.001% in our internal database. The in silico prediction of the variant is damaging MutationTaster2. The reference region is conserved across species.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina sequencing platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA extracted from blood was used to perform targeted gene capture using a custom smMIP panel. The libraries were sequenced to mean &amp;gt;100-300X coverage on the Illumina MiSeq sequencing platform. The sequences obtained are aligned to the human reference genome (GRCh37) using the BWA program and analyzed using Picard and GATK version 4.1.2 to identify variants relevant to the clinical indication.</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2022-06-25" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000926" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002355" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001762" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004614" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003170" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000768" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002751" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNS">
              <Name>galactosamine (N-acetyl)-6-sulfatase</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000512.5:exon 4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">D-6958</Name>
            <Name>p. Pro125Argf sTer4</Name>
          </OtherNameList>
          <FunctionalConsequence Value="Unknown function" />
          <AttributeSet>
            <Attribute Type="HGVS">NM_000512.5:c.374del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253000" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12140418</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5049609" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001762" MappingRef="HP">
        <MedGen CUI="C0009081" Name="Clubfoot" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5049609" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002355" MappingRef="HP">
        <MedGen CUI="C0311394" Name="Difficulty walking" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5049609" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002751" MappingRef="HP">
        <MedGen CUI="C0575158" Name="Kyphoscoliosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5049609" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004614" MappingRef="HP">
        <MedGen CUI="C4025304" Name="Spina bifida occulta at S1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5049609" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000926" MappingRef="HP">
        <MedGen CUI="C1844704" Name="Platyspondyly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5049609" TraitType="Disease" MappingType="XRef" MappingValue="253000" MappingRef="OMIM">
        <MedGen CUI="C0086651" Name="Mucopolysaccharidosis, MPS-IV-A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5049609" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003170" MappingRef="HP">
        <MedGen CUI="C4021739" Name="Abnormal acetabulum morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5049609" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000768" MappingRef="HP">
        <MedGen CUI="C0158731" Name="Pectus carinatum" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

